Cox 1 inhibition by aspirin cyclooxygenase 1. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Blood Platelets Seminal Vesicles Gastric Mucosa Cells, Cultured Endothelium, Vascular Microsomes Macrophages Muscle, Smooth, Vascular Arterioles

Organisms6

Rats, Sprague-Dawley Rats, Wistar Sheep Rabbits Dogs Mice, Inbred C57BL

Diseases14

Asthma, Aspirin-Induced Stomach Ulcer Hemorrhage Gastrointestinal Hemorrhage Thrombosis Myocardial Infarction Inflammation Cardiovascular Diseases Stroke Gastrointestinal Diseases Colorectal Neoplasms Colonic Neoplasms Disease Models, Animal Reye Syndrome

Chemicals and Drugs110

Aspirin Cyclooxygenase 2 Cyclooxygenase 1 Cyclooxygenase Inhibitors Cyclooxygenase 2 Inhibitors Prostaglandin-Endoperoxide Synthases Anti-Inflammatory Agents, Non-Steroidal Dinoprostone Indomethacin Prostaglandins Thromboxane B2 Platelet Aggregation Inhibitors Isoenzymes Arachidonic Acid Ibuprofen Nitrobenzenes Sulfonamides Pyrazoles Lipoxygenase Inhibitors 6-Ketoprostaglandin F1 alpha Arachidonic Acids Epoprostenol Salicylates Membrane Proteins Thromboxane A2 Lipoxygenase Flurbiprofen Thromboxanes Eicosanoids Naproxen Ticlopidine Masoprocol Diclofenac Thromboxane-A Synthase Piroxicam Sodium Salicylate Intramolecular Oxidoreductases Arachidonate 5-Lipoxygenase Hydroxyeicosatetraenoic Acids Receptors, Prostaglandin E Prostaglandins E Meclofenamic Acid Dinoprost Prostaglandins G Thiazines Sulfones Nitric Oxide Lactones 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine 5,8,11,14-Eicosatetraynoic Acid Lipoxins Nitric Oxide Synthase Sulindac Fibrinolytic Agents Acetaminophen Leukotrienes Receptors, Thromboxane RNA, Messenger Enzyme Inhibitors Phospholipases A Ketorolac Phospholipases A2 Prostaglandin Antagonists Prostaglandin H2 Prostaglandin D2 Bradykinin Leukotriene B4 Anticoagulants Arachidonate Lipoxygenases Warfarin 8,11,14-Eicosatrienoic Acid Tablets, Enteric-Coated Tolmetin Receptors, Prostaglandin E, EP4 Subtype Calcimycin Receptors, Prostaglandin E, EP1 Subtype Prostaglandins H Anti-Inflammatory Agents Ketoprofen Hydrazines Receptors, Prostaglandin Interleukin-1 Sulfinpyrazone Lipopolysaccharides 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid NG-Nitroarginine Methyl Ester Nitric Oxide Synthase Type II Receptors, Prostaglandin E, EP2 Subtype 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid Vasodilator Agents Prostaglandins F Receptors, Thromboxane A2, Prostaglandin H2 Peroxidases Electron Transport Complex IV Dipyridamole SRS-A Anticarcinogenic Agents Salicylic Acid Acetylcholine Receptors, Prostaglandin E, EP3 Subtype Vasoconstrictor Agents Nitroarginine Ketorolac Tromethamine NF-kappa B Biological Factors Quinacrine Nitric Oxide Donors Analgesics, Non-Narcotic Phospholipases A2, Cytosolic Prostaglandins I

Analytical, Diagnostic and Therapeutic Techniques and Equipment20

Platelet Function Tests Drug Therapy, Combination Proportional Hazards Models Risk Factors Bleeding Time Prospective Studies Double-Blind Method Treatment Outcome Follow-Up Studies Blotting, Western Cohort Studies Prognosis Immunohistochemistry Risk Assessment Reverse Transcriptase Polymerase Chain Reaction Disease Models, Animal Chemoprevention Incidence Retrospective Studies Drug Administration Schedule

Phenomena and Processes15

Platelet Aggregation Dose-Response Relationship, Drug Time Factors Vasodilation Gene Expression Regulation, Enzymologic Platelet Activation Enzyme Induction Bleeding Time Vasoconstriction Drug Interactions Drug Resistance Signal Transduction Drug Synergism Up-Regulation Kinetics

Disciplines and Occupations1

Immunohistochemistry

Information Science1

Health Care10

Proportional Hazards Models Risk Factors Prospective Studies Double-Blind Method Treatment Outcome Follow-Up Studies Cohort Studies Risk Assessment Incidence Retrospective Studies

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care

Aspirin Cyclooxygenase 2 Cyclooxygenase 1 Cyclooxygenase Inhibitors Cyclooxygenase 2 Inhibitors Prostaglandin-Endoperoxide Synthases Anti-Inflammatory Agents, Non-Steroidal Dinoprostone Indomethacin Prostaglandins Thromboxane B2 Platelet Aggregation Inhibitors Isoenzymes Arachidonic Acid Ibuprofen Nitrobenzenes Sulfonamides Pyrazoles Lipoxygenase Inhibitors 6-Ketoprostaglandin F1 alpha Arachidonic Acids Platelet Aggregation Epoprostenol Salicylates Membrane Proteins Thromboxane A2 Lipoxygenase Flurbiprofen Thromboxanes Eicosanoids Naproxen Ticlopidine Masoprocol Blood Platelets Dose-Response Relationship, Drug Diclofenac Thromboxane-A Synthase Piroxicam Platelet Function Tests Sodium Salicylate Intramolecular Oxidoreductases Arachidonate 5-Lipoxygenase Hydroxyeicosatetraenoic Acids Receptors, Prostaglandin E Prostaglandins E Meclofenamic Acid Dinoprost Prostaglandins G Thiazines Drug Therapy, Combination Seminal Vesicles Sulfones Time Factors Nitric Oxide Lactones Proportional Hazards Models Asthma, Aspirin-Induced 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine 5,8,11,14-Eicosatetraynoic Acid Lipoxins Gastric Mucosa Vasodilation Nitric Oxide Synthase Risk Factors Stomach Ulcer Cells, Cultured Sulindac Fibrinolytic Agents Acetaminophen Leukotrienes Gene Expression Regulation, Enzymologic Endothelium, Vascular Receptors, Thromboxane RNA, Messenger Enzyme Inhibitors Phospholipases A Platelet Activation Enzyme Induction Ketorolac Phospholipases A2 Prostaglandin Antagonists Rats, Sprague-Dawley Bleeding Time Hemorrhage Prospective Studies Prostaglandin H2 Prostaglandin D2 Bradykinin Double-Blind Method Vasoconstriction Leukotriene B4 Anticoagulants Arachidonate Lipoxygenases Warfarin 8,11,14-Eicosatrienoic Acid Drug Interactions Treatment Outcome Tablets, Enteric-Coated Rats, Wistar Tolmetin

No FAQ available that match "cox 1 inhibition by aspirin cyclooxygenase 1"